DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Yeremenko N, Paramarta JE, Baeten D.
The interleukin-23/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis.
Curr Opin Rheumatol 2014;
26: 361-370
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.